Nefazodone: Its place among antidepressants

Annals of Pharmacotherapy

Volumn 30, Issue 9, 1996, Pages 1006-1012

  Cyr, Monica ^a   Brown, Candace S ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; NEFAZODONE; SEROTONIN; SEROTONIN 2 RECEPTOR; TRAZODONE;

ANXIETY; CONSTIPATION; DEPRESSION; HUMAN; NAUSEA; PAIN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SEDATION; SEROTONIN UPTAKE; SEXUAL DYSFUNCTION; VERTIGO; XEROSTOMIA;

EID: 0029793608     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000916     Document Type: Review

References (39)

1. Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990;26:311-5.
2. Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry 1981;38:1160-80.
3. Bigeon A, Grinspoon A, Blumenfeld B, Bleich A, Apter A, Mector R. Increased serotonin-2 receptor binding on blood platelets of suicidal men. Psychopharmacology 1990;100:165-7.
4. Stahl S. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 1994;30:39-43.
5. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psych 1960;23:56-62.
6. Stahl SM. Serotonin neuroscience discoveries usher in a new era of novel drug therapies for psychiatry. Psychopharmacol Bull 1992;28:3-9.
7. 2 agonist DOI. Eur J Pharmacol 1989;161:45-51.
8. 1A receptor challenge in anxiety disorders and depression. In: Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J, eds. Serotonin 1A receptors in depression and anxiety. New York: Raven Press, 1992:135-62.
9. 1A agonist gepirone in depressed patients. Biol Psychiatry 1990;28:73-8.
10. Wieland S, Fischette CT, Lucki I. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology 1993;32:561-73.
11. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 1994;114:559-65.
12. Sharpley AL, Walsh AE, Cowen PJ. Nefazodone - a novel antidepressant - may increase REM sleep. Biol Psychiatry 1992;31:1070-3.
13. Armitage R, Rush AJ, Trivedi M, Cain J, Roffward HP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994;10:123-7.
14. Data on file at the Food and Drug Administration. New York: Bristol-Myers Squibb Co., 1995.
15. Mayol RF, Cole CA, Luke GM, Colson KL, Kerns EH. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma. Drug Metab Dispos 1994;22:304-11.
16. Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety: II. Effects of the serotonin agonist, mCPP, in panic disorder patients and healthy subjects. Psychopharmacology 1987;92:14-24.
17. Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatry 1995; 56(suppl 6):30-6.
18. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980.
19. Rickels K, Schweizer E, Clary C, Fox I, Weise C. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994; 164:802-5.
20. Diagnostic and statistical manual of mental disorders. 3rd ed. Rev. Washington, DC: American Psychiatric Association, 1987.
21. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, et al. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55:234-41.
22. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-82.
23. Feighner JP, Pambakian R, Fowler RC, Boyer WF, D'Amico MF. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. Psychopharmacol Bull 1989;25:219-21.
24. Anton SF, Robinson DS, Roberts DL, Kensler TT, English PA, Archibald DG. Long-term treatment of depression with nefazodone. Psychopharmacol Bull 1994;30:165-9.
25. Package insert. Desyrel (trazodone). Princeton, NJ: Apothecon, 1994.
26. Dunbar GC. An interim overview of the safety and tolerabilty of paroxetine. Acta Psychiatr Scand 1989;80(suppl 350): 135-7.
27. Package insert. Zoloft (sertraline). New York: Pfizer Roerig Pharmaceuticals, 1994.
28. Package insert. Prozac (fluoxetine). Indianapolis, IN: Dista Products, 1994.
29. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J CHn Psychiatry 1996;57(suppl 2):53-62.
30. Biglin KE, Faraon MS, Constance TD, Lieh-Lai M. Drug induced torsades de pointes: a possible interaction of terfenadine and erythromycin (letter). Ann Pharmacother 1994;28:282.
31. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2778-90.
32. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986; 292:660.
33. Sternbach H. The serolonin syndrome. Am J Psychiatry 1991;148:705-13.
34. Ansseau M, Darimont P, Lecoq A, DeNayer A, Evrard JL, Kremer P, et al. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients. Psychopharmacology 1994;115:254-60.
35. Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 1995;56(suppl 6):37-43.
36. Arnoff GM. Trazodone associated with priapism (letter). Lancet 1984;1: 856.
37. Freeman EW, Rickels K, Sondheimer SJ, Denis A, Pfeifer S, Weil S. Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacol 1994;14:180-6.
38. Pick CG, Paul D, Eison MS, Pasternak GW. Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 1992;211:375-81.
39. Cardinale V, ed. Drug topics red book. Montvale, NJ: Medical Economics Data, Inc., 1996.